arrow
E

Eleonora Rosati

azienda ospedaliero universitaria careggi
H指数:27
被引数:2,074

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Predicting epilepsy after new onset refractory status epilepticus due to autoimmune encephalitis: The DAME score
2025-12-010
OAAI
Adjunctive Brivaracetam in People with Epilepsy and Intellectual Disability: Evidence from the BRIVAracetam Add-On First Italian netwoRk Study
2025-03-010
OAAI
Adjunctive cenobamate in people with focal onset seizures: Insights from the Italian Expanded Access Program
2024-08-143
OAAI
Lamotrigine vs levetiracetam in female patients of childbearing age with juvenile absence epilepsy: A Bayesian reanalysis
2024-08-102
PRE
Predictors of Seizure Recurrence in Women With Idiopathic Generalized Epilepsy Who Switch From Valproate to Another Medication
2024-05-145
PRE
Adjunctive brivaracetam and sustained seizure frequency reduction in very active focal epilepsy
2023-09-096
OAAI
Brivaracetam as Early Add-On Treatment in Patients with Focal Seizures: A Retrospective, Multicenter, Real-World Study
2022-09-1611
OAAI
Adjunctive Brivaracetam in Older Patients with Focal Seizures: Evidence from the BRIVAracetam add-on First Italian netwoRk Study (BRIVAFIRST)
2022-03-2812
OAAI
Sustained seizure freedom with adjunctive brivaracetam in patients with focal onset seizures

在局灶性发作发作的患者中,使用辅助的布伐拉西坦持续无癫痫发作

2022-03-2616
OAAI
Adjunctive Brivaracetam in Focal Epilepsy: Real-World Evidence from the BRIVAracetam add-on First Italian netwoRk Study (BRIVAFIRST) (Nov, 10.1007/s40263-021-00856-3, 2021)
2021-11-174
OAAI
Adjunctive Brivaracetam in Focal Epilepsy: Real-World Evidence from the BRIVAracetam add-on First Italian netwoRk STudy (BRIVAFIRST)
2021-09-0234
OAAI
Brivaracetam as add-on treatment in focal epilepsy: A real-world time-based analysis
2020-12-1212
PREAI